| Pharmacological Class |
Selective β2-adrenergic Agonist |
| Mechanism of Action |
CNS Stimulation + Thermogenesis |
| Half-life |
26-34 Hours |
| Administration |
Oral (Pyramidal Protocol) |
| Therapeutic Use |
Bronchodilation (Veterinary) |
| Fat Oxidation |
+12-15% Metabolic Rate |
| Side Effects |
Tremors, Tachycardia, Hypokalemia |
| Cycle Duration |
2 Weeks On/Off |
| Receptor Desensitization |
Significant |
| Detection Window |
4-6 Days |
| Legal Status |
Singapore HSA Class C |
| Common Names |
Clen, Ventipulmin, Spiropent |
| Chemical Name |
1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol |
| Pharmaceutical Brand |
Genesis Metabolic Solutions |
| Production |
Singapore PIC/S GMP Facility |
Reviews
There are no reviews yet.